Holen Sie sich die Stockscreener-App
572.77
0.43%
-2.47
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$575.24
Offen:
$578
24-Stunden-Volumen:
1.86M
Relative Volume:
0.92
Marktkapitalisierung:
$215.19B
Einnahmen:
$43.74B
Nettoeinkommen (Verlust:
$6.58B
KGV:
33.09
EPS:
17.3072
Netto-Cashflow:
$6.11B
1W Leistung:
-3.06%
1M Leistung:
+0.90%
6M Leistung:
+43.78%
1J Leistung:
+9.97%
1-Tages-Spanne:
$569.62
$579.09
1-Wochen-Bereich:
$560.16
$597.68
52-Wochen-Spanne:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
572.77 | 216.12B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.25 | 160.43B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.10 | 57.29B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
145.49 | 41.98B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
225.85 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Stenger Family Office LLC Makes New $1.01 Million Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Mirabella Financial Services LLP Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Epoch Investment Partners Inc. Sells 53,867 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Cresset Asset Management LLC Purchases 7,364 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific: Could Its New Sanofi Site Supercharge America’s Drug Supply Chain? - Smartkarma
Michel Lagarde Sells 32,000 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat
Insider Selling: Thermo Fisher Scientific (NYSE:TMO) COO Sells 30,000 Shares of Stock - MarketBeat
Lagarde of Thermo Fisher sells $12.4m in stock - Investing.com
Lagarde of Thermo Fisher sells $12.4m in stock By Investing.com - Investing.com UK
Will Thermo Fisher's Asia Bioprocessing Tri-Hub Expansion Reshape Thermo Fisher Scientific's (TMO) Narrative? - simplywall.st
Thermo Fisher Scientific expands bioprocessing capabilities in India, Korea and Singapore - chemengonline.com
Regional expansion to accelerate Asian biopharma growth - Labmate Online
Price Over Earnings Overview: Thermo Fisher Scientific - Benzinga
Knuff & Co LLC Sells 3,559 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stake Cut by Kennedy Capital Management LLC - MarketBeat
$1.22 Bn Cell Therapy Packaging Market Industry Trends and Global Forecasts to 2035: Growth Driven by Shift From Broad-Spectrum Treatments to Personalized Therapeutic Development - GlobeNewswire Inc.
Thermo Fisher Scientific Inc. $TMO Shares Sold by Baird Financial Group Inc. - MarketBeat
Amundi Lowers Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Can Thermo Fisher Scientific Inc. (TN8) stock sustain double digit ROE2025 AllTime Highs & Technical Analysis for Trade Confirmation - Newser
Thermo Fisher’s New Asia Bioprocessing Network Might Change The Case For Investing In Thermo Fisher Scientific (TMO) - Yahoo Finance
Thermo Fisher Scientific expands Bioprocess Design Centers to strengthen Asia’s biopharma manufacturing capacity - BioMelbourne Network
Insider Selling: Thermo Fisher Scientific (NYSE:TMO) EVP Sells 6,912 Shares of Stock - MarketBeat
Frederick Lowery Sells 6,913 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat
Thermo Fisher Scientific (TMO): Reassessing Valuation After Recent Share Price Gains - simplywall.st
BioNexus gets $500M to step into manufacturing; Thermo Fisher, AtomVie expand - Endpoints News
What Made Thermo Fisher Scientific (TMO) a Solid Performer in Q3? - Insider Monkey
How Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock gains from tech spendingJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - Newser
GENinCode Plc (AIM: GENI) up 33% on Thermo Fisher commercialisation deal - Share Talk
GENinCode surges on Thermo Fisher deal to roll out heart-disease test - Proactive Investors
GENinCode Partners with Thermo Fisher for CARDIO inCode-Score® Expansion - TipRanks
Thermo Fisher Scientific(TMO.US) Officer Sells US$8.15 Million in Common Stock - 富途牛牛
Thermo Fisher launches purpose-built next-gen triple quad mass spec - SelectScience
Jim Cramer Says He Feels “Particularly Good About” Thermo Fisher - Insider Monkey
Thermo Fisher Scientific Insider Sold Shares Worth $8,154,131, According to a Recent SEC Filing - marketscreener.com
Thermo Fisher Scientific (TMO) SVP & General Counsel reports Form 4 stock sale - Stock Titan
Thermo Fisher (TMO) EVP Lowery discloses December 2025 option exercises and share sales - Stock Titan
TMO (NYSE: TMO) insider Michel Lagarde files Form 144 to sell 32,000 shares - Stock Titan
TMO Stock Benefits From New Bioprocess Design Center in Asia - TradingView
Westerkirk Capital Inc. Buys Shares of 17,000 Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Expands Bioprocessing Capabilities Across Asia - Contract Pharma
Groupe la Francaise Raises Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
New Bioprocess Design Center In Hyderabad Boosts Thermo Fisher’s Asian Bioprocessing Capabilities - Sahyadri Startups
India could scale semiconductor manufacturing faster than expected, says Thermo Fisher leaders - ET Manufacturing
Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers - BioSpectrum Asia
Thermo Fisher expands bioprocessing capabilities across Asia - Investing.com
Thermo Fisher expands bioprocessing capabilities across Asia By Investing.com - Investing.com India
Thermo Fisher (TMO) boosts Asia biopharma support with new and expanded design centers - Stock Titan
COO Lagarde Files To Sell 30,000 Of Thermo Fisher Scientific Inc [TMO] - TradingView
Thermo Fisher Scientific (TMO) insider files to sell 30,000 shares worth 17,457,611.41 - Stock Titan
Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 Featuring Strategic Profiles of Key P - PharmiWeb.com
Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts - ts2.tech
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):